Active Specific Immunotherapy with an Autologous Virus-modified Tumour Cell Vaccine in Human Renal Cell Carcinoma (RCC)

By Hinkel A.   de Riese W.   Alefelder J.   Laumann D.   Falkenberg F.W.   Senge T.   Hertle L.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1719-1720

Elsevier

Access to resources Recommend Favorite

Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation

By                          

International Journal of Oncology, Vol. 47, Iss. 6, 2015-01 ,pp. : 2073-2081

Spandidos Publications

Access to resources Recommend Favorite

TGLI1 Upregulates Expression of VEGFR2 and VEGF-A, Leading to a Robust VEGF-VEGFR2 Autocrine Loop and Cancer Cell Growth

By Han Woody   Carpenter Richard L.   Lo Hui-Wen  

Cancer Hallmarks, Vol. 1, Iss. 1, 2013-03 ,pp. : 28-37

American Scientific Publishers

Access to resources Recommend Favorite

Whole-cell vaccine coated with recombinant calreticulin enhances activation of dendritic cells and induces tumour-specific immune responses

By              

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 529-534

Spandidos Publications

Access to resources Recommend Favorite

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokineinduced killer cell therapy in hepatobiliary and pancreatic cancer

By              

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 129-133

Science Publishers

Access to resources Recommend Favorite